Gefitinib Accord

Gefitinib Accord is an oral medication used to treat certain types of cancer. This pharmaceutical is designed to target specific proteins involved in cancer cell growth.

Gefitinib Accord is primarily used in the treatment of non-small cell lung cancer (NSCLC) that has specific genetic markers. It works by inhibiting the epidermal growth factor receptor (EGFR), which can help slow the growth and spread of cancer cells. Patients often wonder, 'What is Gefitinib used for?' and the answer lies in its targeted approach to cancer therapy.

Common effects of Gefitinib Accord may include skin rash, diarrhea, and fatigue. Some users might also experience nausea or loss of appetite. These effects can vary from person to person and are not exhaustive.

Gefitinib Accord should be handled with care, especially for those with pre-existing medical conditions. It is important to follow the advice of a healthcare professional regarding its use. Always store the medication as directed to maintain its efficacy.

Gefitinib Accord may interact with certain medications, including those that are metabolized by the liver. It is advisable to inform your healthcare provider about all medications you are taking to avoid potential interactions. Alcohol consumption should also be discussed with a healthcare professional.